Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
SHOPPING: Streamline your beauty routine in the new year with the all-in-one skin-perfecting stick that works as both a concealer and a foundation to reduce imperfections and leave you glowing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback